Skip to content

Drug interactions

Amiodarone + Lomitapide

Severity: Major

Amiodarone and Lomitapide: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lomitapide is highly dependent on CYP3A4, and amiodarone is a weak to moderate inhibitor that can raise lomitapide exposure. This raises the risk of hepatotoxicity and gastrointestinal adverse effects. Amiodarone itself can also cause liver injury.

What this interaction means in plain words

Amiodarone and Lomitapide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Amiodarone belongs to Cardiovascular; Lomitapide belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Amiodarone inhibits CYP3A4, reducing lomitapide clearance, with additive hepatotoxic potential.

What to do

Monitor liver enzymes closely and reduce the lomitapide dose per labeling for weak inhibitors. Consider an alternative to amiodarone.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Amiodarone and Lomitapide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Amiodarone with Lomitapide?

MediHelp rates the interaction as major. Amiodarone and Lomitapide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Lomitapide is highly dependent on CYP3A4, and amiodarone is a weak to moderate inhibitor that can raise lomitapide exposure. This raises the risk of hepatotoxicity and gastrointestinal adverse effects. Amiodarone itself can also cause liver injury.

How serious is the interaction between Amiodarone and Lomitapide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver enzymes closely and reduce the lomitapide dose per labeling for weak inhibitors. Consider an alternative to amiodarone.

What other medicines interact with Amiodarone?

MediHelp also lists interactions of Amiodarone with, for example, Amisulpride, Arsenic trioxide, Dofetilide. The full list is on the Amiodarone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in